Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Historical Holders from Q1 2020 to Q3 2025

Symbol
BDTX on Nasdaq
CUSIP
09203E105
Type / Class
Equity / Common Stock
Shares outstanding
56.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
38.8M
Holdings value
$147M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
89
Number of buys
49
Number of sells
-45
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BB BIOTECH AG 4.8% -68.7% $3.88M -$8.21M 2.73M -67.9% BB Biotech AG Mar 19, 2025
BlackRock, Inc. 4.5% $3.58M 2.52M BlackRock, Inc. Mar 31, 2025

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 38.8M $147M +$5.64M $3.79 89
2025 Q2 38.6M $95.8M -$4.38M $2.48 92
2025 Q1 40.7M $63M -$11.8M $1.55 83
2024 Q4 47.9M $103M -$13.8M $2.14 84
2024 Q3 48.7M $212M +$1.57M $4.35 101
2024 Q2 46.5M $217M +$31.8M $4.66 87
2024 Q1 39.4M $200M +$10.4M $5.07 85
2023 Q4 38.9K $109K +$77.6K $2.81 1
2023 Q3 37.2M $107M -$21.9M $2.87 69
2023 Q2 41.4M $209M +$105M $5.05 69
2023 Q1 21.5M $40.6M +$847K $1.89 46
2022 Q4 21.1M $37.9M -$752K $1.80 54
2022 Q3 21.5M $36.3M -$315K $1.69 54
2022 Q2 21M $51.6M -$3.65M $2.46 54
2022 Q1 20.1M $55.6M -$1.85M $2.77 63
2021 Q4 20.2M $108M -$13.4M $5.33 77
2021 Q3 23.6M $200M -$12.5M $8.46 86
2021 Q2 24.8M $302M -$88.6M $12.19 96
2021 Q1 29.1M $706M -$7.56M $24.26 109
2020 Q4 26.9M $863M +$135M $32.05 107
2020 Q3 23.8M $718M +$754K $30.23 87
2020 Q2 22.8M $956M +$40.7M $42.16 77
2020 Q1 22.3M $555M +$555M $24.95 64